—Symposium Reviews— |
|
The Power of Young Researcher Responsible for Medicinal Chemistry in Following Generation |
| ………K. Motoshima and R. Shinozaki |
…315 |
|
Nitric Oxide Donors Activated by Two-Photon Excitation |
| ………K. Hishikawa, H. Nakagawa, and N. Miyata |
…317 |
|
Structural Development Study of a Novel Pharmacological Chaperone for Folding-defective Rhodopsin Mutants Responsible for Retinitis Pigmentosa |
| ………K. Ohgane, K. Dodo, and Y. Hashimoto |
…325 |
|
Comprehensive Synthetic Study of Muraymycins toward the Development of Novel Antibacterial Agents |
| ………T. Tanino, S. Ichikawa, K. Uotani, H. Oyama, and A. Matsuda |
…335 |
|
Signi<0136>cance and Creation of Novel Cyclooxygenase-1 (COX-1) Selective Inhibitors |
| ………R. Fukai, X. Zheng, K. Motoshima, and H. Kakuta |
…347 |
|
Molecular Toxicology Led by Young Scientists 5-Biological Systems to Determine the Sensitivity to Chemicals- |
| ………Y. Fujiwara and T. Kimura |
…353 |
|
Studies on Molecular Mechanism of Toxicity of Anticancer Drugs |
| ………T. Takahashi |
…355 |
|
The Mechanism for Subcellular Localization of Nuclear Receptor CAR |
| ………Y. Kanno and Y. Inouye |
…359 |
|
Biology of Diesel Exhaust Effects on Allergic Pulmonary Inflammation |
| ………K. Inoue and H. Takano |
…367 |
|
A Heritage of Pharmacognosy and Its Innovation-Trials from Academic, Investigative and Clinical Perspective |
| ………M. Ito |
…373 |
|
Introduction of “Clinical Pharmacognosy“ -Integration between Pharmacognosy and Clinical Pharmacy- |
| ………T. Makino |
…375 |
|
Recent Progress of International Harmonization of Crude Drugs and Medicinal Plants-Activity of FHH (The Western Pacific Regional Forum for the Harmonization of Herbal Medicines)- |
| ………N. Kawahara |
…383 |
|
History of the Nippon Shinyaku Institute for Botanical Research |
| ………T. Yamaura |
…395 |
|
What Does “Pharmacognosy“ Mean for Pharmacists? |
| ………K. Kawazoe |
…401 |
—Reviews— |
|
Clinical Usefulness of Limited Sampling Strategies for Estimating AUC of Proton Pump Inhibitors |
| ………T. Niioka |
…407 |
|
Sex- and Species-differences on Xenobiotic-induced Toxicity: Differences in Constitutive and Xenobiotic-mediated Expression of Cytochrome P450 1A Subfamily Enzymes (CYP1As) |
| ………M. Sekimoto |
…415 |
—Regular Articles— |
|
Anti-arthritic Active Fraction of Capparis Spinosa L. Fruits and Its Chemical Constituents |
| ………X. Feng, J. Lu, H. Xin, L. Zhang, Y. Wang, and K. Tang |
…423 |
|
A Special Focus on the Role of α1D-Adrenoreceptors in the Assessment of Renal Tubular Sodium Re-absorptive Responses in Spontaneously Hypertensive Rats Subjected to High Sodium Diet |
| ………R. N. Kazi, M. A. Sattar, N. A. Abdullah, M. A. H. Khan, H. A. Rathore, M. H. Abdulla, I. M. Salman, and E. J. Johns |
…431 |
|
Reno-protective Role of Flunarizine (Mitochondrial Permeability Transition Pore Inactivator) against Gentamicin Induced Nephrotoxicity in Rats |
| ………A. Muthuraman, S. K. Singla, A. Rana, A. Singh, and S. Sood |
…437 |
|
Investigation into the Effect of Gastric Secretion Inhibitor for the Prevention of Upper Gastrointestinal Lesions Associated with Low-dose Aspirin |
| ………H. Nakamura, H. Yokoyama, T. Yaguchi, Y. Suzuki, K. Tokuoka, M. Watanabe, Y. Kitagawa, and Y. Yamada |
…445 |
|
Alteration of P-gp Expression after Intestinal Ischemia-reperfusion Following 16-h Fasting in Rats |
| ………J. Ogura, A. Fujikawa, H. Maruyama, M. Kobayashi, S. Itagaki, and K. Iseki |
…453 |
|
Dose Conversion in Opioid Rotation from Continuous Intravenous Infusion of Morphine Hydrochloride Injection to Fentanyl Patch in the Management of Cancer Pain |
| ………C. Kawano, T. Hirayama, and M. Kuroyama |
…463 |
—Notes— |
|
Case-controlled Study on Risk Factors for the Development of Constipation in Hospitalized Patients |
| ………T. Ueki, K. Nagai, N. Ooe, M. N. Nakashima, K. Nishida, J. Nakamura, and M. Nakashima |
…469 |
|
Educational Effects of Learning through Simulation of Diabetes Drug Therapy |
| ………C. Kikuchi, E. Hori, T. Maeda, T. Matsunaga, and T. Suzuki |
…477 |